Serial testing of refugees for latent tuberculosis using the quantiFERON-gold In-tube: Effects of an antecedent tuberculin skin test

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 4, 2009, Pages 628-633

  Baker, Cristina A ^a,b   Thomas, William ^a,b   Stauffer, William M ^a   Peterson, Phillip K ^a   Tsukayama, Dean T ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENDEMIC DISEASE; EVALUATION; FEMALE; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POPULATION EXPOSURE; PROSPECTIVE STUDY; REFUGEE; REPRODUCIBILITY; SCREENING; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; ADOLESCENT; AFRICA; CHINA; MICROBIOLOGICAL EXAMINATION; RUSSIAN FEDERATION; SENSITIVITY AND SPECIFICITY; UKRAINE;

ADOLESCENT; ADULT; AFRICA; CHINA; FEMALE; HUMANS; MALE; MICROBIOLOGICAL TECHNIQUES; PROSPECTIVE STUDIES; REFUGEES; REPRODUCIBILITY OF RESULTS; RUSSIA; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; UKRAINE; UNITED STATES;

EID: 65349152438     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.628     Document Type: Article

References (20)

1. Centers for Disease Control, 2008.Trends in tuberculosis-United States, 2007. Morbid Mortal Wkly Rev MMWR 57:281-285.
2. Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, Mussini C, Rumpianesi F, Fabbri LM, Richeldi L, 2006. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367:1328-1334.
3. Shah SS, McGowan JP, Klein RS, Converse PJ, Blum S, Gourevitch MN, 2006. Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users. Med Sci Monit 12: MT11-MT16.
4. Taggart EW, Hill HR, Ruegner RG, Litwin CM, 2006. Evaluation of an in vitro assay for interferon gamma production in response to the Mycobacterium tuberculosis-synthesized peptide antigens ESAT-6 and CFP-10 and the PPD skin test. Am J Clin Pathol 125: 467-473.
5. Menzies D, Pai M, Comstock G, 2007. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354.
6. Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM, 2006. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis 6:47.
7. Mahomed H, Hughes EJ, Hawkridge T, Minnies D, Simon E, Little F, Hanekom WA, Geiter L, Hussey GD, 2006. Comparison of mantoux skin test with three generations of a whole blood IFN- gamma assay for tuberculosis infection. Int J Tuberc Lung Dis 10:310-316.
8. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM Jr, 2005. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 293:2746-2755.
9. Winje BA, Oftung F, Korsvold GE, Mannsaker T, Jeppesen AS, Harstad I, Heier BT, Heldal E, 2008. Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test. BMC Infect Dis 8:65.
10. Menzies D, 1999. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159:15-21.
11. Cauthen GM, Snider DE Jr, Onorato IM, 1994. Boosting of tuberculin sensitivity among Southeast Asian refugees. Am J Respir Crit Care Med 149:1597-1600.
12. Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, Arend SM, 2007. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific IFN-{gamma) assay. Eur Respir J 29:1212-1216.
13. Naseer A, Naqvi S, Kampmann B, 2007. Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6 weeks following tuberculin skin testing. Eur Respir J 29: 1282-1283.
14. Choi JC, Shin JW, Kim JY, Park IW, Choi BW, Lee MK, 2008. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest 133:1415-1420.
15. Graham P, Bull B, 1998. Approximate standard errors and confidence intervals for indices of positive and negative agreement. / Clin Epidemiol 51:763-771.
16. Cohen J, 1960. A coefficient of agreement for nominal scales. Educ Psychol Meas 20: 37-46.
17. Farhat M, Greenaway C, Pai M, Menzies D, 2006. False-positive tuberculin skin tests: what is the absolute effect of BCG and non- tuberculous mycobacteria? IntJTuberc Lung Dis 10:1192-1204.
18. Carvalho AC, Pezzoli MC, El-Hamad I, Arce P, Bigoni S, Scarcella C, Indelicate AM, Scolari C, Carosi G, Matteelli A, 2007. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect 55:164-168.
19. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, Reingold AL, Colford JM Jr, Riley LW, Menzies D, 2006. Serial testing of health care workers for tuberculosis using interferon- gamma assay. Am J Respir Crit Care Med 174:349-355.
20. Cain KP, Benoit SR, Winston CA, Mac Kenzie WR, 2008. Tuberculosis among foreign-born persons in the United States. JAMA 300:405-412.